Journal of Microbiology, Immunology and Infection (Apr 2022)
Hemodialysis acutely altered interferon-gamma release assay test result and immune cell profile
Abstract
Patients receiving hemodialysis (HD) are at risk of TB development. IGRA-positive patients showed significant decrease in quantitative IGRA result with alterations in CD3+CD4+CD45RO+, NK cell, and monocyte subsets immediately upon HD procedure. Our result suggested that the timing of IGRA testing is crucial in end-stage renal disease population.